Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Chemed Corporation (NYSE: CHE) failed to manage Chemed in an acceptable manner, breaching their fiduciary duties to Chemed, and whether Chemed and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know:

• On August 13, 2026, The Capital Forum released a report alleging that Chemed may be overbilling Medicare for continuous home care by tens of millions of dollars annually. Chemed previously entered into a $75 million settlement and a 5-year corporate integrity agreement with the Department of Health and Human Services for similar false Medicare claims.
• If you own Chemed common stock, join our investigation on behalf of Chemed and its shareholders by filling out the form here.

If you own Chemed common stock and you wish to discuss this investigation—at no cost for you—please contact attorney Joe Pettigrew toll-free at (844) 818-6982 or jpettigrew@scott-scott.com.

About this investigation – FAQ:

Q1: What is this ongoing investigation into Chemed about?

A: According to our investigation, owners of Chemed common stock have been impacted by allegations that Chemed is overbilling Medicare for tens of millions of dollars each year for continuous home care services. Scott+Scott has a decades-long track record in fighting for corporate governance and monetary recoveries on behalf of companies and their shareholders.

Q2: How does this Scott+Scott investigation work?

A: Joining our investigation is easy and at no cost for you. By filling out the form here, we will let you know your rights as a Chemed shareholder, and how the process works and what you can expect. If you currently own Chemed stock, we look forward to hearing from you.

To learn more about Scott+Scott, our attorneys, or complex case resolution, please visit www.scott-scott.com.

Attorney Advertising

View source version on businesswire.com: https://www.businesswire.com/news/home/20260820450060/en/

Scott+Scott Attorneys at Law LLP, an international securities and consumer rights litigation firm, is investigating whether the directors of Chemed Corporation (NYSE: CHE) breached their fiduciary duties to Chemed and its shareholders.